BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 35187860)

  • 1. Proteomic profiling of sporadic late-onset nemaline myopathy.
    Naddaf E; Dasari S; Selcen D; Charlesworth MC; Johnson KL; Mauermann ML; Kourelis T
    Ann Clin Transl Neurol; 2022 Mar; 9(3):391-402. PubMed ID: 35187860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular signatures of inherited and acquired sporadic late onset nemaline myopathies.
    Nicolau S; Dasgupta A; Dasari S; Charlesworth MC; Johnson KL; Pandey A; Doles JD; Milone M
    Acta Neuropathol Commun; 2023 Jan; 11(1):20. PubMed ID: 36703211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sporadic Late-Onset Nemaline Myopathy: Current Landscape.
    Nicolau S; Milone M
    Curr Neurol Neurosci Rep; 2023 Nov; 23(11):777-784. PubMed ID: 37856049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sporadic late-onset nemaline myopathy: clinico-pathological characteristics and review of 76 cases.
    Schnitzler LJ; Schreckenbach T; Nadaj-Pakleza A; Stenzel W; Rushing EJ; Van Damme P; Ferbert A; Petri S; Hartmann C; Bornemann A; Meisel A; Petersen JA; Tousseyn T; Thal DR; Reimann J; De Jonghe P; Martin JJ; Van den Bergh PY; Schulz JB; Weis J; Claeys KG
    Orphanet J Rare Dis; 2017 May; 12(1):86. PubMed ID: 28490364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sporadic late onset nemaline myopathy and immunoglobulin deposition disease.
    Doppler K; Knop S; Einsele H; Sommer C; Wessig C
    Muscle Nerve; 2013 Dec; 48(6):983-8. PubMed ID: 23873431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sporadic late onset nemaline myopathy with concurrent dermatological symptoms responding to immunosuppressive treatment.
    Nandy A; Tankisi H; Krøigård AB; Dalager MG; Hvidbjerg MS; Schrøder HD; Obál I
    BMC Neurol; 2023 Jun; 23(1):233. PubMed ID: 37328820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory features in sporadic late-onset nemaline myopathy are independent from monoclonal gammopathy.
    Tanboon J; Uruha A; Arahata Y; Dittmayer C; Schweizer L; Goebel HH; Nishino I; Stenzel W
    Brain Pathol; 2021 May; 31(3):e12962. PubMed ID: 34043258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy-based approach is the preferred treatment for sporadic late-onset nemaline myopathy with a monoclonal protein.
    Kotchetkov R; Susman D; Bhutani D; Broch K; Dispenzieri A; Buadi FK
    Int J Cancer; 2021 Jun; 148(11):2807-2814. PubMed ID: 33529362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sporadic late-onset nemaline myopathy: clinical, pathology and imaging findings in a single center cohort.
    Monforte M; Primiano G; Silvestri G; Mirabella M; Luigetti M; Cuccagna C; Ricci E; Servidei S; Tasca G
    J Neurol; 2018 Mar; 265(3):542-551. PubMed ID: 29356967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Two cases of sporadic late onset nemaline myopathy effectively treated with immunotherapy].
    Mizuno Y; Mori-Yoshimura M; Okamoto T; Oya Y; Nishino I; Murata M
    Rinsho Shinkeigaku; 2016 Sep; 56(9):605-11. PubMed ID: 27580764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sporadic late-onset nemaline myopathy: Clinical spectrum, survival, and treatment outcomes.
    Naddaf E; Milone M; Kansagra A; Buadi F; Kourelis T
    Neurology; 2019 Jul; 93(3):e298-e305. PubMed ID: 31167932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coexisting sporadic late onset nemaline myopathy and AL amyloid myopathy - incidental or related?
    Moshe-Lilie O; Banks G; Medvedova E; Masri A; Chahin N
    Neuromuscul Disord; 2022 Jun; 32(6):533-538. PubMed ID: 35550111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sporadic late onset nemaline myopathy responsive to IVIg and immunotherapy.
    Milone M; Katz A; Amato AA; Soderland CA; Segarceanu M; Young NP; Jones HR
    Muscle Nerve; 2010 Feb; 41(2):272-6. PubMed ID: 19852026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathologic Profiles of Sporadic Late-Onset Nemaline Myopathy: Practical Importance of Anti-α-Actinin Immunostaining.
    Zhao B; Dai T; Zhao D; Ma X; Zhao C; Li L; Sun Y; Zhang Y; Yan Y; Lu JQ; Liu F; Yan C
    Neurol Neuroimmunol Neuroinflamm; 2022 Jul; 9(4):. PubMed ID: 35581006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel ACTA1 mutation causing progressive facioscapuloperoneal myopathy in an adult.
    Kao JC; Liewluck T; Milone M
    J Clin Neurosci; 2018 Jul; 53():261-262. PubMed ID: 29731279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Camptocormia as the presenting symptom in sporadic late onset nemaline myopathy: a case report.
    Türk M; Nagel AM; Roemer F; Schlötzer-Schrehardt U; Thiel CT; Winterholler M; Schröder R
    BMC Musculoskelet Disord; 2019 Nov; 20(1):553. PubMed ID: 31747907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sporadic late onset nemaline myopathy (SLONM) in an adult presenting with progressive muscle weakness.
    Paramalingam S; Dyke JM; Nossent JC
    Eur J Rheumatol; 2019 Apr; 6(2):105-107. PubMed ID: 30407167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noteworthy Cardiovascular Involvement with Sporadic Late-onset Nemaline Myopathy.
    Matsuzono K; Kumutpongpanich T; Kubota K; Okuyama T; Furuya K; Yagisawa T; Horikiri A; Igarashi T; Miura K; Ozawa T; Mashiko T; Shimazaki H; Koide R; Tanaka R; Shimizu H; Imai Y; Kario K; Nishino I; Fujimoto S
    Intern Med; 2021 Jul; 60(14):2327-2332. PubMed ID: 33612671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sporadic late-onset nemaline myopathy as a rare cause of slowly progressive muscle weakness with young adult onset.
    Maeda MH; Ohta H; Izutsu K; Shimizu J; Uesaka Y
    Muscle Nerve; 2015 May; 51(5):772-4. PubMed ID: 25381859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Sporadic late-onset nemaline myopathy with monoclonal gammopathy of undetermined significance mimicking POEMS syndrome].
    Kanamori T; Kusumoto S; Okita K; Hagiwara S; Kato C; Nakashima T; Murakami S; Narita T; Ito A; Ri M; Ishida T; Komatsu H; Matsukawa N; Iida S
    Rinsho Ketsueki; 2018; 59(2):161-166. PubMed ID: 29515067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.